Skip to content

InterSPACE: feasibility of an integrated telehealth and self-management programme for individuals hospitalised with an exacerbation of COPD

InterSPACE: feasibility of an integrated telehealth and self-management programme for individuals hospitalised with an exacerbation of COPD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN13081008
Enrollment
100
Registered
2015-01-12
Start date
2015-05-08
Completion date
Unknown
Last updated
2021-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory COPD exercabations Respiratory Chronic obstructive pulmonary disease

Interventions

Participants are given access to the self-management programme. Participants are supported through the programme for 3 months, but have access for a year. The tablet computers are preloaded with the w

Sponsors

University Hospitals of Leicester NHS Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients admitted with a primary diagnosis of exacerbation COPD. This may include patients with existing disease or patients who are newly diagnosed on admission to hospital. All patients who are admitted into the Glenfield Hospital with an exacerbation of or newly diagnosed COPD will be screened for eligibility i.e. willing to take part in this pilot study. Individuals do not necessarily have WiFi access and so a 3G connection is provided as part of the package. Eligible patients will however need to have a current email account and be computer literate. Willing participants will be given full instructions on how to access the SPACE self-management programme website via their chosen device.

Exclusion criteria

Exclusion criteria: 1. Unwilling to participate 2. Individuals with significant co-morbidities to limit physical activity 3. Unable to read or write English 4. Not computer literate

Design outcomes

Primary

MeasureTime frame
The reason for this project is to understand the feasibility and acceptability of the novel tablet based self management support at the time of a hospital discharge. The primary consideration for the study will be uptake and acceptability. Uptake will be reported and web usage will be closely monitored through a sophisticated web monitoring component embedded in the existing site.

Secondary

MeasureTime frame
Current secondary outcome measures as of 21/03/2016: 1. Readmission rates, measured using hospital record checks 2. Health-related quality of life, measured using CAT and CRQ questionnaire 3. Anxiety and depression, measured using HADS questionnaire 4. Physical activity, measured using PACER questionnaire 5. Impact on clinical team (staff time/cost) 6. Patient and clinician thoughts about the study and intervention, assessed using qualitative interviews Collected at 3 and 6 months. Previous secondary outcome measures: 1. Health-related quality of life 2. Anxiety and depression 3. Hospital readmissions These will be collected at baseline and after 6 and 12 months.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 17, 2026